TotalMarketCap

Sagimet Biosciences

SGMTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$642.626 M

$9.11 -8.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Sagimet Biosciences (SGMT) has a market capitalization of $642.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$51.0M

Loss-making

Shares outstanding

42,893,900

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #164Lexicon PharmaceuticalsLXRX$723.1M
  2. #165Ironwood PharmaceuticalsIRWD$657.7M
  3. #166Sagimet BiosciencesSGMT$642.6M
  4. #167Wave Life SciencesWVE$638.0M
  5. #168Zevra TherapeuticsZVRA$626.6M

What if Sagimet Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$400,335.96

Per share 43,940× higher

Bitcoin $1.53T

$21,661.48

Per share 2,378× higher

Apple $5.02T

$71,112.62

Per share 7,805× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Sagimet Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.